After mapping the cast, the people, and the money, I kept hitting one question: why does all of this cost so much? America spends roughly twice what peer countries spend per person — and doesn’t get better health to show for it. Here’s what I found, and it’s not one villain.
Prices, not volume. The first surprise: Americans don’t use much more healthcare than people in other rich countries. We just pay far more per unit. The same MRI, the same drug, the same procedure — priced multiples higher. The US is the only rich country that mostly lets sellers name their price.
The billing machine. Thousands of health plans, each with its own rules, codes, and prior-auth forms. Providers employ armies just to bill and collect — billing staff, coders, claim fighters. (See the life of a medical bill.) It’s an order of magnitude more overhead than countries with single payment systems, and every dollar of it comes out of premiums.
Fee-for-service. Pay per thing done, and you’ll get more things done. More scans, more procedures, more revenue — whether or not the patient is better off. The payment model is an engine for volume.
Consolidation. Hospitals keep merging, and merged systems gain pricing power. A “must-have” hospital system in a city can name its price to health plans — and the plans pass it to you in premiums.
Drugs. America pays the highest drug prices in the world, by far. Other countries negotiate as one buyer; the US mostly doesn’t.
Here’s the uncomfortable synthesis: there’s no single villain because there’s no single cause. It’s the design. Every actor — the hospital, the plan, the drugmaker, the device company — is responding rationally to what they’re paid for. The system isn’t broken in the sense of malfunctioning. It’s functioning exactly as its incentives dictate. Which means the costs aren’t an accident. They’re the output.
Previously: the life of a medical bill. Next: the patient journey, end to end.